GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ferozsons Laboratories Ltd (KAR:FEROZ) » Definitions » Market Cap

Ferozsons Laboratories (KAR:FEROZ) Market Cap : ₨13,017 Mil (As of Apr. 08, 2025)


View and export this data going back to 1960. Start your Free Trial

What is Ferozsons Laboratories Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ferozsons Laboratories's share price for the quarter that ended in Dec. 2024 was ₨335.35. Ferozsons Laboratories's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 43 Mil. Therefore, Ferozsons Laboratories's market cap for the quarter that ended in Dec. 2024 was ₨14,577 Mil.

Ferozsons Laboratories's quarterly market cap increased from Jun. 2024 (₨10,842 Mil) to Sep. 2024 (₨12,625 Mil) and increased from Sep. 2024 (₨12,625 Mil) to Dec. 2024 (₨14,577 Mil).

Ferozsons Laboratories's annual market cap declined from Jun. 2022 (₨9,741 Mil) to Jun. 2023 (₨5,949 Mil) but then increased from Jun. 2023 (₨5,949 Mil) to Jun. 2024 (₨10,842 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ferozsons Laboratories's Enterprise Value for Today is ₨16,938 Mil.


Ferozsons Laboratories Market Cap Historical Data

The historical data trend for Ferozsons Laboratories's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ferozsons Laboratories Market Cap Chart

Ferozsons Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,069.02 12,780.61 9,741.04 5,948.73 10,841.60

Ferozsons Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,591.00 9,538.84 10,841.60 12,625.14 14,577.33

Competitive Comparison of Ferozsons Laboratories's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Ferozsons Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ferozsons Laboratories's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ferozsons Laboratories's Market Cap distribution charts can be found below:

* The bar in red indicates where Ferozsons Laboratories's Market Cap falls into.


;
;

Ferozsons Laboratories Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Ferozsons Laboratories's Market Cap for the fiscal year that ended in Jun. 2024 is calculated as

Market Cap (A: Jun. 2024 )=Share Price (A: Jun. 2024 )*Shares Outstanding (EOP) (A: Jun. 2024 )
=₨249.41*43.469
=₨10,842

Ferozsons Laboratories's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=₨335.35*43.469
=₨14,577

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ferozsons Laboratories  (KAR:FEROZ) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Ferozsons Laboratories Market Cap Related Terms

Thank you for viewing the detailed overview of Ferozsons Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Ferozsons Laboratories Business Description

Traded in Other Exchanges
N/A
Address
5.K.M - Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and oncology. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. It operates in three segments namely Ferozsons; BF Biosciences; and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.

Ferozsons Laboratories Headlines

No Headlines